Navigation Links
Patients Presenting Medication Lists Reduce the Risk of Error During Hospital Admission
Date:5/6/2010

Study finds 85 percent of medication errors originate in patients' medication histories; more than half of those errors are caused by failure to report medications at admissions

CHICAGO, May 6 /PRNewswire-USNewswire/ -- A recent study conducted at Northwestern Memorial Hospital found that almost 50 percent of medication discrepancies were related to a failure to understand all of the prescription medications patients were taking at the time of hospital admission.  While it's common for patients not to recall all of their medications, especially when they are not feeling well or being unexpectedly admitted to the hospital, the results can be serious. The study, one of the largest conducted among hospitalized patients, highlighted the need for hospitals to modify processes and for healthcare providers to strongly encourage patients to keep a comprehensive and up-to-date list of all medications they are taking.

"When a patient is admitted to a hospital they typically receive new medications or have changes made to their existing prescriptions.  Since the new medication regimen may conflict with drugs that patients are already taking, it is imperative that physicians and patients have an open dialogue and discuss current prescriptions and over-the-counter medications. Even common pain killers like Tylenol must be reported," said Gary Noskin, MD, professor of medicine at Northwestern University Feinberg School of Medicine, associate chief medical officer at Northwestern Memorial and principal investigator for the study.

The study, designed to determine risk factors and potential harm associated with medication errors at hospital admission, was published in the Journal of General Internal Medicine. Results
'/>"/>

SOURCE Northwestern Memorial Hospital
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
3. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. Many Heart Attack Patients Dont Get Best Emergency Treatment
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
11. MedImmune Initiates Phase 2a Multi-Dose Study in Patients with Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... Dec. 23, 2014   Synageva BioPharma Corp. ... company developing therapeutic products for rare disorders, today ... of the Marketing Authorization Application (MAA) for sebelipase ... the company,s request for accelerated assessment, which has ... time.   The MAA, and the ...
(Date:12/24/2014)...  The American Diabetes Association is recommending a ... with diabetes and that all people with diabetes ... in keeping with recent changes to guidelines for ... of Cardiology (ACC) and American Heart Association (AHA). ... changes to the Association,s annual revised Standards of ...
(Date:12/24/2014)... N.C. , Dec. 23, 2014  Endo Pharmaceuticals ... ENDP ) (TSX: ENL), and BioDelivery Sciences International, ... they have submitted a New Drug Application (NDA) for ... Drug Administration (FDA).  Buprenorphine HCl Buccal Film is under ... require daily, around-the-clock, long-term opioid treatment and for which ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 2New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 3New Standards of Care Provide Guidelines for Statin Use for People with Diabetes to Prevent Heart Disease 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
... 2011 Today, Children,s Hospital at Scott ... and the only stand-alone facility between Dallas and Austin, opened ... used Scott & White,s state-of-the-art Simulation Center for a mock ... housed in Scott & White Hospital-Temple, before moving patients to ...
... 4, 2011 /PRNewswire/ -- PLC Systems Inc. ... technologies, today announced that it had signed an agreement ... to distribute its innovative RenalGuard System™ in France and ... ACIST will be the exclusive distributor of PLC,s RenalGuard® ...
Cached Medicine Technology:Children's Hospital at Scott & White Opens 2Children's Hospital at Scott & White Opens 3Children's Hospital at Scott & White Opens 4PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany 2PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany 3PLC Systems Signs ACIST Medical Systems, to Distribute RenalGuard® in France and Germany 4
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... BETHESDA, Md., Aug. 19 /PRNewswire-Asia/ -- Chindex ... independent American provider of Western,healthcare products and services in ... entered into a contract to supply EUR5 million in,laboratory ... China,s,Qinghai Province. The purchase is being financed by the ...
... , ELM GROVE, Wis., Aug. 19 A webinar on JCAHO ... partment Core Measures: A c hieving Successful Quality Outcomes ... to aid Hospital Emergency Departments in instituting treatment standards as ... CAP patients. Compliance with JCAHO Core Measures produces better outcomes for ...
... warn of toxic buildup from paraffin, suggest beeswax instead ... candles, used mainly for romantic ambiance, fragrance and light, ... , The candles, which are made from petroleum, are ... researchers said in a study to be presented Wednesday ...
... , WASHINGTON, Aug. 19 The ... Tobacco-Free Kids: , , (Logo: http://www.newscom.com/cgi-bin/prnh/20080918/CFTFKLOGO ... and Drug Administration announcement today that it is establishing the Center ... highly respected and experienced public health leader, as the Center Director ...
... , , , ... and Prevention (CDC)(1) and LYSOL(R) brand products are proud to announce the launch ... www.oop k i ds.com , an interactive site ... was created in a continued effort to educate children and their parents about ...
... workers, new federal guidelines say , WEDNESDAY, Aug. 19 ... keeping employees six-feet apart are all ways to reduce ... America,s businesses, government experts said in new guidelines issued ... as the fall/winter flu season approaches, because the extent ...
Cached Medicine News:Health News:Chindex International, Inc. Announces New CDC Contract 2Health News:Chindex International, Inc. Announces New CDC Contract 3Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 2Health News:Compirion Hosts Free Webinar on Achieving JCAHO-Compliant Quality Outcomes 3Health News:Tobacco-Free Kids Welcomes Formation of FDA's Center for Tobacco Products and Selection of Center Director 2Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 2Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 3Health News:The CDC and Lysol Partner to Educate Kids About How to Help Protect Themselves From Harmful Germs 4Health News:Businesses Need Swine Flu Action Plan: Experts 2Health News:Businesses Need Swine Flu Action Plan: Experts 3
For the quantitative in vitro determination of Digoxin in human serum....
For the quantitative in vitro determination of Microalbumin in urine....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT)by STA Analyzers (ISI~1.8).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
Medicine Products: